BioAge says experimental pill aimed at reducing heart risks significantly reduced inflammation The company, like others, is betting reduced inflammation can lead to better health outcomes

https://www.statnews.com/2026/04/21/bioage-drug-inflammation-cardiovascular-risks/ By Elaine ChenApril 21, 2026 Elaine Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech.